Vistin Pharma ASA 2023 SR
The report outlines Vistin Pharma's sustainability program, 'Balance by Vistin,' which focuses on three pillars: healthy environment, people in focus, and clean operations. Key environmental targets include a 90% reduction in water consumption through a new recycling plant and a 90% reduction in VOC emissions by 2024. The company highlights its low carbon footprint, utilizing 100% Norwegian hydropower for its energy-intensive Metformin HCl production. Vistin Pharma also maintains a surveillance program to monitor its impact on the local fjord ecosystem and ensures compliance with the 2023 Norwegian Transparency Act.
Company: Vistin Pharma ASA
Sector: Health Care
Country: Norway
Year: 2023
Type: SR
Pages: 5
Vistin Pharma ASA
Sustainability Report
The report outlines Vistin Pharma's sustainability program, 'Balance by Vistin,' which focuses on three pillars: healthy environment, people in focus, and clean operations. Key environmental targets include a 90% reduction in water consumption through a new recycling plant and a 90% reduction in VOC emissions by 2024. The company highlights its low carbon footprint, utilizing 100% Norwegian hydropower for its energy-intensive Metformin HCl production. Vistin Pharma also maintains a surveillance program to monitor its impact on the local fjord ecosystem and ensures compliance with the 2023 Norwegian Transparency Act.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Employees